Literature DB >> 25589304

Factors Associated with Late Engagement to HIV Care in Western Kenya: A Cross-Sectional Study.

Charles Meja Kwobah1,2, Paula Braitstein3,2,4,5, Julius K Koech3, Gilbert Simiyu3, Ann W Mwangi3,6, Kara Wools-Kaloustian3,4, Abraham M Siika3,2.   

Abstract

BACKGROUND: Late presentation of patients contributes significantly to the high mortality reported in HIV -care and treatment programs in sub-Saharan Africa.
METHODS: A cross-sectional study was conducted to assess factors associated with late engagement to HIV care at the Academic Model Providing Access to Healthcare in western Kenya. Late engagement was defined as baseline CD4 ≤100 cells/mm3.
RESULTS: Of the 10 533 participants included in the analysis, 67% were female and mean age was 36.7 years. Overall, 23% of the participants presented late. Factors associated with late engagement included male gender (adjusted odds ratio [AOR]: 1.54, 95% confidence interval [CI]: 1.35-1.75), older age (AOR: 1.62, 95% CI: 1.02-2.56), and longer travel time to clinic (AOR: 1.18, 95% CI: 1.04-1.34).
CONCLUSION: Nearly one-quarter of HIV-infected patients in our setting present with advanced immune suppression at initial encounter. Being male, older age, and living further away from clinic are associated with late engagement to care.
© The Author(s) 2015.

Entities:  

Keywords:  HIV; advanced immune suppression; late presentation

Mesh:

Year:  2015        PMID: 25589304     DOI: 10.1177/2325957414567682

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  8 in total

1.  Epidemiological profile of individuals diagnosed with HIV: results from the preliminary phase of case-based surveillance in Kenya.

Authors:  Richelle Harklerode; Wanjiru Waruiru; Felix Humwa; Anthony Waruru; Timothy Kellogg; Lilly Muthoni; James Macharia; Emily Zielinski-Gutierrez
Journal:  AIDS Care       Date:  2019-04-27

2.  Immunological Response During HAART and Determinants of Current CD4+ T-Cell Count Among HIV/AIDS Patients Attending University of Gondar Referral Hospital, Northwest Ethiopia.

Authors:  Gizachew Ayele Manaye; Dejene Derseh Abateneh; Kindie Mitiku Kebede; Alemayehu Sayih Belay
Journal:  HIV AIDS (Auckl)       Date:  2020-07-31

3.  Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.

Authors:  Lemma Derseh Gezie
Journal:  BMC Res Notes       Date:  2016-07-30

4.  Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia.

Authors:  Lemma Derseh Gezie; Kassahun Alemu Gelaye; Abebaw Gebeyehu Worku; Tadesse Awoke Ayele; Destaw Fetene Teshome
Journal:  BMC Res Notes       Date:  2017-07-14

5.  Effective linkage from point of HIV testing to care and treatment in Tanga region, Tanzania.

Authors:  David Elias Kayabu; James Samwel Ngocho; Blandina Theophil Mmbaga
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

6.  Barriers to HIV care in Uganda and implications for universal test-and-treat: a qualitative study.

Authors:  Sarah M Lofgren; Sharon Tsui; Lynn Atuyambe; Leander Ankunda; Robina Komuhendo; Nathan Wamala; Alisat Sadiq; Paul Kirumira; Diksha Srishyla; Andrew Flynn; Katelyn A Pastick; David B Meya; Noeline Nakasujja; Carolyn Porta
Journal:  AIDS Care       Date:  2021-07-27

7.  Advanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study.

Authors:  Mia Liisa van der Kop; Lehana Thabane; Patricia Opondo Awiti; Samuel Muhula; Lennie Bazira Kyomuhangi; Richard Todd Lester; Anna Mia Ekström
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

8.  Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.

Authors:  Abraham Aregay Desta; Tewolde Wubayehu Woldearegay; Asfawosen Aregay Berhe; Nesredin Futwi; Goyitom Gebremedhn Gebru; Hagos Godefay
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.